Our products

COMMERCIAL NAME (A-Z)	ACTIVE PRINCIPLE	TYPE
BIVIS	Olmesartan medoxomil/amlodipine	Drug
BRETARIS	Aclidinium bromide	Drug
BRIMICA	Aclidinium bromide/formoterol fumarate	Drug
GIBITER	Budesonide/formoterol fumarate	Drug
GLIBOMET	Glibenclamide/metformin	Drug
GLIBORAL	Glibenclamide	Drug
GLUCOFERRO	Zinc gluconate	Drug
GLURENOR	Gliquidone	Drug
INVOKANA	Canagliflozin	Drug
LACIREX	Lacidipine	Drug
METFORAL	Metformin	Drug
METFORALMILLE	Metformin	Drug
PLAUNAC	Olmesartan medoxomil	Drug
PLAUNAZIDE	Olmesartan medoxomil/hydroclorothiazide	Drug
RILAMIG	Frovatriptan	Drug
RILATEN	Rociverine	Drug
SOLOSA	Glimepiride	Drug
TOTALIP	Atorvastatin	Drug
UNOPROST	Terazosin	Drug
VOKANAMET	Canagliflozin/metformin	Drug
ZECOVIR	Brivudine	Drug
ZETAMICIN	Netilmicin sulfate	Drug

Serving the doctor - Privacy

An outstanding history. A successful present. A promising future. This is Guidotti, a company whose desire to constitute a permanent point of reference for the doctor is one of the distinguishing features of its commitment.

Drug quality comes first
Menarini Research: high-level research

Among the Menarini Ricerche S.p.a., the commitment in study and Develop has increased with time. Today Menarini Ricerche S.p.a. includes, among its pharmacological researchers, people of high knowledge of the national and worldwide areas.

Laboratori Guidotti S.p.A.

Registered Office:
Via Livornese, 897 - 56122 Pisa - Loc. La Vettola (Italy)
Tel. 050/971011

Single Member Company
Registration No. In Registrar Of Companies: 00678100504
Registrar Of Companies' Office: Pisa
Registered Capital: € 4.200.000 fully paid-in
Capital Reported In Last Financial Statement: € 4.200.000
Company subject to the direction and coordination of
A. Menarini Industrie Farmaceutiche Riunite Srl

Our products

Serving the doctor - Privacy

Drug quality comes first Menarini Research: high-level research

Drug quality comes first
Menarini Research: high-level research